Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ: KRMD )

2.480 -0.010 (-0.40%)
Streaming Delayed Price Updated: 3:45 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025
From KORU Medical Systems, Inc.
Via Business Wire
Top movers in Friday's pre-market session
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Analyst Expectations For KORU Medical Systems's Future
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Friday's pre-market session: top gainers and losers
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
Earnings Scheduled For March 12, 2025
Via Benzinga
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
From KORU Medical Systems, Inc.
Via Business Wire
This Informatica Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
From KORU Medical Systems, Inc.
Via Business Wire
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KRMD Stock Earnings: KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024
KRMD stock results show that KORU Medical Systems beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
From KORU Medical Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.